Pathophysiology of vascular endothelium and circulating platelets: implications for coronary revascularisation and treatment

被引:9
作者
Amoroso, G
van Veldhuisen, DJ
Tio, RA
Mariani, M
机构
[1] Univ Groningen Hosp, Thoraxctr, NL-9700 RB Groningen, Netherlands
[2] Univ Pisa, Cardiothorac Dept, Pisa, Italy
关键词
endothelium; platelets; coronary revascularisation;
D O I
10.1016/S0167-5273(01)00448-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Constant vasodilatation, inhibition of platelet and leukocyte adhesion, and local thrombolysis are the mechanisms through which an intact endothelial layer exerts its protective action on coronary circulation. A loss in these features is not only the first step in the development of atherosclerosis, but also a potent trigger for complications after revascularisation procedures. Percutaneous coronary interventions, particularly in the course of stenting, induce endothelial injury that can last up to months after the procedure. On the other hand, the preservation of endothelial function appears the best feature of arterial versus venous grafts after coronary bypass surgery. An early diagnosis either by invasive or non-invasive techniques has important implications for prognosis, and endothelial dysfunction can be effectively counteracted by medical treatment (ACE inhibitors, statins). Activated circulating platelets are present in the course of coronary artery disease, increasing the risk of thrombotic occlusion and/or plaque regrowth, after both percutaneous and surgical revascularisation. New antiplatelet agents are under development to reduce endothelium-platelet interaction. On the basis of the latest studies, coronary revascularisation should be integrated in a more complete treatment, which would take into account the complex processes involving the underlying atherosclerotic plaque. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 82 条
[1]   Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [J].
Al Suwaidi, J ;
Hamasaki, S ;
Higano, ST ;
Nishimura, RA ;
Holmes, DR ;
Lerman, A .
CIRCULATION, 2000, 101 (09) :948-954
[2]  
Albiero R, 1997, CIRCULATION, V95, P1145
[3]   EFFECT OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY ON CIRCULATING ENDOTHELIN LEVELS [J].
AMELI, S ;
KAUL, S ;
CASTRO, L ;
ARORA, C ;
MIREA, A ;
SHAH, PK .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (18) :1352-1356
[4]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[5]   ASPIRIN AND DIPYRIDAMOLE IN THE PREVENTION OF ACUTE CORONARY-THROMBOSIS COMPLICATING CORONARY ANGIOPLASTY [J].
BARNATHAN, ES ;
SCHWARTZ, JS ;
TAYLOR, L ;
LASKEY, WK ;
KLEAVELAND, JP ;
KUSSMAUL, WG ;
HIRSHFELD, JW .
CIRCULATION, 1987, 76 (01) :125-134
[6]   ANGIOGRAPHIC ASSESSMENT OF HUMAN CORONARY-ARTERY ENDOTHELIAL FUNCTION BY MEASUREMENT OF ENDOTHELIUM-DEPENDENT VASODILATION [J].
BOSSALLER, C ;
HEHLERTFRIEDRICH, C ;
JOST, S ;
RAFFLENBEUL, W ;
LICHTLEN, P .
EUROPEAN HEART JOURNAL, 1989, 10 :44-48
[7]  
Brown BG, 1998, AM J CARDIOL, V82, p49T
[8]   Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease [J].
Cahill, MR ;
Macey, MG ;
Dawson, JR ;
Newland, AC .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :165-168
[9]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[10]   Long-term endothelial dysfunction after coronary artery stenting [J].
Caramori, PRA ;
Lima, VC ;
Seidelin, PH ;
Newton, GE ;
Parker, JD ;
Adelman, AG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (06) :1675-1679